4O8I image
Deposition Date 2013-12-27
Release Date 2014-06-11
Last Version Date 2023-09-20
Entry Detail
PDB ID:
4O8I
Keywords:
Title:
1.45A resolution structure of PEG 400 Bound Cyclophilin D
Biological Source:
Source Organism:
Homo sapiens (Taxon ID: 9606)
Host Organism:
Method Details:
Experimental Method:
Resolution:
1.45 Å
R-Value Free:
0.18
R-Value Work:
0.15
R-Value Observed:
0.16
Space Group:
P 21 21 21
Macromolecular Entities
Structures with similar UniProt ID
Protein Blast
Polymer Type:polypeptide(L)
Molecule:Peptidyl-prolyl cis-trans isomerase F, mitochondrial
Gene (Uniprot):PPIF
Mutagens:K133I
Chain IDs:A
Chain Length:165
Number of Molecules:1
Biological Source:Homo sapiens
Ligand Molecules
Primary Citation
High-resolution crystal structures of two crystal forms of human cyclophilin D in complex with PEG 400 molecules.
Acta Crystallogr F Struct Biol Commun 70 717 722 (2014)
PMID: 24915078 DOI: 10.1107/S2053230X14009480

Abstact

Cyclophilin D (CypD) is a key mitochondrial target for amyloid-β-induced mitochondrial and synaptic dysfunction and is considered a potential drug target for Alzheimer's disease. The high-resolution crystal structures of primitive orthorhombic (CypD-o) and primitive tetragonal (CypD-t) forms have been determined to 1.45 and 0.85 Å resolution, respectively, and are nearly identical structurally. Although an isomorphous structure of CypD-t has previously been reported, the structure reported here was determined at atomic resolution, while CypD-o represents a new crystal form for this protein. In addition, each crystal form contains a PEG 400 molecule bound to the same region along with a second PEG 400 site in CypD-t which occupies the cyclosporine A inhibitor binding site of CypD. Highly precise structural information for CypD should be extremely useful for discerning the detailed interaction of small molecules, particularly drugs and/or inhibitors, bound to CypD. The 0.85 Å resolution structure of CypD-t is the highest to date for any CypD structure.

Legend

Protein

Chemical

Disease

Primary Citation of related structures
Feedback Form
Name
Email
Institute
Feedback